Erica Duncan is a Manager, Pricing and Evidence at PDCI. Her role includes research and project support for market access and pricing assessments. Erica manages and supports Human Drug Advisory Panel (HDAP) filling submissions by assessing and reviewing the clinical evidence and the scientific information cross-functionally with our clinical team. She also provides insights on reimbursement trends and PMPRB pricing policies and strategies.
Prior to joining PDCI, Erica worked at Converge Advertising, managing the development and execution of Canadian medical education and strategic pharmaceutical marketing programs in numerous therapeutic areas. Erica’s experience includes engagements with Canadian clinicians, payers, government representatives, and PMPRB officials.